A cluster of genes located in 1p36 are down-regulated in neuroblastomas with poor prognosis, but not due to CpG island methylation

[1]  S. Nilsson,et al.  Mutations in the N-terminal domain of DFF45 in a primary germ cell tumor and in neuroblastoma tumors. , 2004, International journal of oncology.

[2]  H. Carén,et al.  A novel 1p36.2 located gene, APITD1, with tumour-suppressive properties and a putative p53-binding domain, shows low expression in neuroblastoma tumours , 2004, British Journal of Cancer.

[3]  W. Gerald,et al.  Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma. , 2004, Journal of the National Cancer Institute.

[4]  J. Herman,et al.  Gene silencing in cancer in association with promoter hypermethylation. , 2003, The New England journal of medicine.

[5]  J. Herman,et al.  Clustering of hypermethylated genes in neuroblastoma , 2003, Genes, chromosomes & cancer.

[6]  P. Kogner,et al.  Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2 , 2003, Oncogene.

[7]  Catherine Morrissey,et al.  Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers , 2003, Oncogene.

[8]  Long-Cheng Li,et al.  MethPrimer: designing primers for methylation PCRs , 2002, Bioinform..

[9]  M. Esteller.  CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future , 2002, Oncogene.

[10]  Kenichi Harada,et al.  Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines , 2002, Oncogene.

[11]  C. Krona,et al.  Analyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma tumours , 2002, British Journal of Cancer.

[12]  C. Eng,et al.  RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours , 2001, Oncogene.

[13]  M. Schwab,et al.  Smallest region of overlapping deletion in 1p36 in human neuroblastoma: A 1 Mbp cosmid and PAC contig , 2001, Genes, chromosomes & cancer.

[14]  R. Versteeg,et al.  Three chromosomal rearrangements in neuroblastoma cluster within a 300‐kb region on 1p36.1 , 2001, Genes, chromosomes & cancer.

[15]  C. Plass,et al.  Methylation matters , 2001, Journal of medical genetics.

[16]  R. Versteeg,et al.  Chromosome bands 1p35–36 contain two distinct neuroblastoma tumor suppressor loci, one of which is imprinted , 2001, Genes, chromosomes & cancer.

[17]  Yoshiyuki Sakaki,et al.  Identification and characterization of a 500-kb homozygously deleted region at 1p36.2-p36.3 in a neuroblastoma cell line , 2000, Oncogene.

[18]  P. Kogner,et al.  Fine mapping of the human preprocortistatin gene (CORT) to neuroblastoma consensus deletion region 1p36.3→p36.2, but absence of mutations in primary tumors , 2000, Cytogenetic and Genome Research.

[19]  F. Behm,et al.  Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN , 2000, Nature Medicine.

[20]  B. Tycko,et al.  Epigenetic gene silencing in cancer. , 2000, The Journal of clinical investigation.

[21]  Peter A. Jones,et al.  Cancer-epigenetics comes of age , 1999, Nature Genetics.

[22]  M. Davey,et al.  Urea improves efficiency of bisulphite-mediated sequencing of 5'-methylcytosine in genomic DNA. , 1998, Nucleic acids research.

[23]  F. Hedborg,et al.  Delimitation of a critical tumour suppressor region at distal 1p in neuroblastoma tumours. , 1997, European Journal of Cancer.

[24]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[25]  F. Hedborg,et al.  Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms. , 1995, Cancer research.

[26]  A. Look,et al.  Significance of chromosome 1p loss of heterozygosity in neuroblastoma. , 1995, Cancer research.

[27]  A T Look,et al.  A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[28]  F. Speleman,et al.  Evidence for two tumour suppressor loci on chromosomal bands 1p35-36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification. , 1995, Human molecular genetics.

[29]  S. Clark,et al.  High sensitivity mapping of methylated cytosines. , 1994, Nucleic acids research.

[30]  Christoph Plass,et al.  Cancer epigenomics. , 2002, Human molecular genetics.

[31]  D. Stram,et al.  Comprehensive analysis of chromosome 1p deletions in neuroblastoma. , 2001, Medical and pediatric oncology.

[32]  T. Matise,et al.  Detailed molecular analysis of 1p36 in neuroblastoma. , 2001, Medical and pediatric oncology.

[33]  P. Ambros,et al.  Fine mapping of a tumour suppressor candidate gene region in 1p36.2-3, commonly deleted in neuroblastomas and germ cell tumours. , 2001, Medical and pediatric oncology.